Manning & Napier Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-89,090
Closed -$18.9M 279
2021
Q2
$18.9M Sell
89,090
-10,526
-11% -$2.22M 0.16% 128
2021
Q1
$20.3M Sell
99,616
-139,947
-58% -$27.6M 0.17% 127
2020
Q4
$43.6M Sell
239,563
-6,565
-3% -$1.12M 0.41% 72
2020
Q3
$41.2M Sell
246,128
-101,500
-29% -$17.1M 0.42% 69
2020
Q2
$56.5M Buy
347,628
+520
+0.1% +$93.2K 0.6% 56
2020
Q1
$60M Sell
347,108
-20,395
-6% -$4.06M 0.71% 48
2019
Q4
$73.8M Sell
367,503
-22,770
-6% -$4.67M 0.8% 38
2019
Q3
$82.5M Sell
390,273
-36,157
-8% -$7.55M 0.92% 30
2019
Q2
$82.8M Buy
426,430
+51,235
+14% +$9.45M 0.9% 31
2019
Q1
$61.7M Sell
375,195
-12,040
-3% -$2.13M 0.68% 40
2018
Q4
$72.8M Buy
387,235
+322,160
+495% +$59.5M 0.89% 37
2018
Q3
$11.1M Buy
+65,075
New +$11M 0.11% 127

Other funds holding CME

Manning & Napier Group's CME Position: Q3 2021 in Review

Manning & Napier Group sold out of CME Group (CME) in Q3 2021, closing a stake of 89,090 shares — an estimated $18.9M sold.

Manning & Napier Group first reported a position in CME in Q3 2018 and held it in 12 quarters. The position peaked at $82.8M in Q2 2019. 1,054 funds tracked by Wall St. Rank hold CME as of Q3 2021.

  • Manning & Napier Group reported no remaining CME Group position as of Q3 2021 after selling out during the quarter.
  • Manning & Napier Group sold 89,090 CME Group shares in Q3 2021, an estimated $18.9M.
  • Manning & Napier Group first reported a position in CME Group in Q3 2018 and held it in 12 quarters.
  • Manning & Napier Group's CME Group position peaked at $82.8M in Q2 2019.
  • 1,054 funds tracked by Wall St. Rank held CME Group as of Q3 2021.

Based on Manning & Napier Group's 13F filing for Q3 2021, filed 14 Oct 2021.